Peterborough Regional Health Centre (PRHC) president and CEO Dr. Lynn Mikula will be leaving the hospital this fall to take on the top leadership role at Sinai Health in Toronto.
According to an announcement from PRHC’s board of directors, Dr. Mikula will become president and CEO of Sinai Health in October 2026. Sinai Health includes Mount Sinai Hospital, an acute care hospital, and Hennick Bridgepoint Hospital, a rehabilitation hospital, both affiliated with the University of Toronto Faculty of Medicine.
“Lynn’s leadership has had a lasting impact on PRHC,” said board chair Scott Milligan in a media release. “Over the course of her time here, she has brought clarity to the organization’s direction, strengthened its foundation, and helped to build a strong, collaborative leadership culture.”
“We are so grateful for Lynn’s many contributions to this organization over the last 15 years, and for the vision, drive and energy that have earned such widespread recognition and respect,” Milligan added. “While we will be sad to see her go, this move is a testament to both her leadership and the incredible mark she has made on the broader healthcare system in her time with PRHC.”
Dr. Mikula joined PRHC in 2011 as a staff general surgeon and went on to hold a series of senior leadership roles, including chief of staff, chief medical executive, and executive vice-president. She also served as the hospital’s executive lead during the COVID-19 pandemic.
In 2023, PRHC’s board appointed Dr. Mikula as president and CEO.
“PRHC and the Peterborough community have been central to my life and career,” Dr. Mikula said. “I am deeply grateful for the trust and support I’ve received over the years from our board of directors, our leadership team, and the staff and physicians I am so fortunate to call my colleagues, as well as our partners, volunteers, and donors who make this hospital the great place it is.”
“While this next step means I will be leaving PRHC, the people and the sense of purpose here matter deeply to me, and they always will. PRHC is a critical hub for the broad and diverse population it serves, and I am very proud of the work we’re doing to advance its role across the region. Between now and my departure this fall, my focus is on ensuring a smooth and steady transition and supporting the organization to continue moving forward with confidence.”
Under Dr. Mikula’s leadership, PRHC launched a five-year strategic plan, one of Canada’s first nursing strategies, a workplace well-being framework, and its first equity and reconciliation strategy, including the addition of an Indigenous navigator role at the hospital.
During Dr. Mikula’s time as president and CEO, the regional hospital also opened its Reactivation Care Centre, introduced implantable cardioverter defibrillator procedures through its cardiac program, developed a custom data analytics platform, and established a formal partnership with Trent University to support research.
PRHC was also named one of Canada’s Best Employers by Forbes in 2025 and 2026, designated as an age-friendly health system by the Institute for Healthcare Improvement, and received Accreditation with Exemplary Standing for the third consecutive time in 10 years.
“While we have continued to experience a number of systemic challenges over the years, I’m incredibly proud of the work our people have done to set this organization apart as a leader in transformation, adaptation and innovation among our hospital peers,” Dr. Mikula said. “I look forward to celebrating the amazing things this team will continue to achieve in the months and years ahead.”
Dr. Mikula’s move to Sinai Health marks her return to Toronto’s so-called “hospital row,” one of the largest and most advanced biomedical and healthcare innovation clusters in North America.
After obtaining her Doctor of Medicine and Master of Surgery from McGill University, she completed her residency in general surgery at the University of Toronto, during which she trained at Mount Sinai Hospital and earned a Master of Science degree at the Lunenfeld-Tanenbaum Research Institute.
PRHC’s board of directors said it will work with Dr. Mikula and the hospital’s leadership team over the coming months to ensure a smooth transition.
